Epilepsy in the developing world

Current Neurology and Neuroscience Reports

Volumn 9, Issue 4, 2009, Pages 319-326

  Carpio, Arturo ^a   Hauser, W Allen ^b  

^a UNIVERSIDAD DE CUENCA   (Ecuador)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYSTICIDAL; PHENOBARBITAL; UNCLASSIFIED DRUG;

BEHAVIOR DISORDER; BRAIN EDEMA; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME INDUCTION; EPILEPSY; HEALTH CARE DELIVERY; HUMAN; HYPERACTIVITY; INCIDENCE; MALARIA; MORTALITY; NEUROCYSTICERCOSIS; PARAGONIMIASIS; PREVALENCE; PROGNOSIS; RECURRENCE RISK; REMISSION; RESTLESSNESS; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; TEMPORAL LOBECTOMY; TOXOCARIASIS; ARTICLE; BRAIN; CLINICAL TRIAL; DEVELOPED COUNTRY; HEALTH CARE COST; RECURRENT DISEASE; SEIZURE;

ANTICONVULSANTS; BRAIN; CLINICAL TRIALS AS TOPIC; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EPILEPSY; HEALTH CARE COSTS; HUMANS; INCIDENCE; NEUROCYSTICERCOSIS; PREVALENCE; PROGNOSIS; RECURRENCE; RISK FACTORS; SEIZURES;

EID: 67651214192     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0048-z     Document Type: Review

References (58)

1. The World Bank: Global Economic Prospects 2004: Realizing the Development Promise of the Doha Agenda. Available at http://siteresources.worldbank.org/INTRGEP2004/Resources/ gep2004fulltext.pdf. Accessed May 21, 2009.
2. Bharucha NE, Carpio A, Gallo Diop A: Epidemiology of epilepsy in developing countries. In Epilepsy: A Comprehensive Textbook, edn 2. Edited by Engel P, Pedley T. Philadelphia: Lippincott Williams & Wilkins; 2008:89-101.
3. World Health Organization: Atlas: Epilepsy Care in the World. Geneva: World Health Organization; 2005.
4. Wang WZ, Wu JZ, Wang DS, et al.: The prevalence and treatment gap in epilepsy in China: An ILAE/IBE/WHO study. Neurology 2003, 60:1544-1545.
5. Birbeck GL, Kalichi EM: EpilepsA prevalence in rural Zambia: a door-to-door survey. Trop Med Int Health 2004, 9:92-95.
6. Ndoye NF, Sow AD, Diop AG, et al.: Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure 2005, 14:106-111.
7. Mungala-Odera V, White S, Meehan R, et al.: Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya. Seizure 2008, 17:396-404.
8. Edwards T, Scott AG, Munyoki G, et al.: Active convulsive epilepsy in a rural district of Kenya: A study of prevalence and possible risk factors. Lancet Neurol 2008, 7:50-56.
9. Noronha AL, Borges MA, Marques LH, et al.: Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia 2007, 48:880-885.
10. Melcon MO, Kochen S, Vergara RH: Prevalence and clinical features of epilepsy in Argentina. A community-based study. Neuroepidemiology 2007, 28:8-15.
11. Del Brutto OH, Santibanez R, Idrovo L, et al.: Epilepsy and neurocysticercosis in Atahualpa: A door-to-door survey in rural coastal Ecuador. Epilepsia 2005, 46:583-587.
12. Dent W, Helbok R, Matuja WB, et al.: Prevalence of active epilepsy in a rural area in South Tanzania: A door-to-door survey. Epilepsia 2005, 46:1963-1969.
13. Medina MT, Duron RM, Martinez L, et al.: Prevalence, incidence, and etiology of epilepsies in rural Honduras: The Salama study. Epilepsia 2005, 46:124-131.
14. Calisir N, Bora I, Irgil E, Boz M: Prevalence of epilepsy in Bursa city center, an urban area of Turkey. Epilepsia 2006, 47:1691-1699.
15. Tran DS, Odermatt P, Le TO, et al.: Prevalence of epilepsy in a rural district of central of Lao PDR. Neuroepidemiology 2006, 26:199-206.
16. Tuan NA, Cuong le Q, Allebeck P, et al.: The prevalence of epilepsy in a rural district of Vietnam: A population-based study from the EPIBAVI project. Epilepsia 2008, 49:1634-1637.
17. Bielen I, Cvitanovic-Sojat L, Bergman-Markovic B, et al.: Prevalence of epilepsy in Croatia: A population-based survey. Acta Neurol Scand 2007, 116:361-367.
18. Banerjee PN, Hauser WA: Incidence and prevalence. In Epilepsy: A Comprehensive Textbook, edn 2. Edited by Engel P, Pedley T. Philadelphia: Lippincott Williams & Wilkins; 2008:45-56.
19. DoguiIM, Jallon P, Tamallah JB, et al.: Episousse: incidence of newly presenting seizures in children in the Region of Sousse, Tunisia. Epilepsia 2003, 44:1441-1444.
20. Benn EK, Hauser WA, Shih T, et al.: Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of Northern Manhattan, New York City. Epilepsia 2008, 49:1431-1439.
21. Beghi E, Sander JW: The natural history and prognosis of epilepsy. In Epilepsy: A Comprehensive Textbook, edn 2. Edited by Engel P, Pedley T. Philadelphia: Lippincott Williams & Wilkins; 2008:65-70.
22. Carpio A, Bharucha NE, Jallon P, et al.: Mortality of epilepsy in developing countries. Epilepsia 2005, 46(Suppl11): 28-32.
23. Ding D, Wang W, Wu J, et al.: Premature mortality in people with epilepsy in rural China: A prospective study. Lancet Neurol 2006, 5:823-827.
24. Kaiser C, Asaba G, Kasoro S, et al.: Mortality from epilepsy in an onchocerciasis-endemic area in West Uganda. Trans R Soc Trop Med Hyg 2007, 101:48-55.
25. Daoud AS, Ajloni S, El-Salem K, et al.: Risk of seizure recurrence after a first unprovoked seizure: A prospective study among Jordanian children. Seizure 2004, 13:99-103.
26. Kochen S, Melcon MO: Prognosis of epilepsy in a community-based study: 8 years of follow-up in an Argentine community. Acta Neurol Scand 2005, 112:370-374.
27. Scotoni AE, Manreza ML, Guerreiro MM: Recurrence after a first unprovoked cryptogenic/idiopathic seizure in children: A prospective study from Sao Paulo, Brazil. Epilepsia 2004, 45:166-170.
28. Carpio A, Hauser W: Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002, 59:1730-1734.
29. Terra-Bustamante VC, Coimbra ER, Rezek KO, et al.: Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis. J Neurol Neurosurg Psychiatry 2005, 76:1080-1083.
30. Garcia H, Pretell E, Gilman R, et al.: A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004, 350: 249-258.
31. De Souza A, Thennarasu K, Yeshraj G, et al.: Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: Effect on long-term seizure outcome. J Neurol Sci 2009, 276:108-114.
32. Thussu A, Chattopadhyay A, Sawhney IM, Khandelwal N: Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. J Neurol Neurosurg Psychiatry 2008, 79:272-275.
33. Carpio A, Kelvin E, Bagiella E, et al.: The effects of albendazole treatment on neurocysticercosis: A randomized controlled trial. J Neurol Neurosurg Psychiatry 2008, 79:1050-1055.
34. Das K, Mondal GP, Banerjee M, et al.: Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: An 8 year randomised study. J Clin Neurosci 2007, 14:1172-1177.
35. Chen RC, Chang YC, Chen TH, et al.: Mortality in adult patients with epilepsy in Taiwan. Epileptic Disord 2005, 7:215-219.
36. Carpio A, Hauser WA: Remote symptomatic epilepsies and epileptic syndromes: Etiological spectrum. In Epilepsy in the Tropics. Edited by Murthy JMK, Senanayke N. Georgetown, TX: Landes Bioscience; 2006:72-84.
37. Carter JA, Neville BG, White S, et al.: Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia 2004, 45:978-981.
38. Singh G, Singh P, Singh I, et al.: Epidemiologic classification of seizures associated with neurocysticercosis: Observations from a sample of seizure disorders in neurologic care in India. Acta Neurol Scand 2006, 113:233-240.
39. Winkler AS, Blocher J, Auer H, et al.: Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg 2008, 102:1032-1038.
40. Montano SM, Villaran MV, Ylquimiche L, et al.: Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 2005, 65:229-223.
41. Prasad KN, Prasad A, Gupta RK, et al.: Neurocysticercosis in patients with active epilepsy from the pig farming community of Lucknow district, north India. Trans R Soc Trop Med Hyg 2009, 103:144-150.
42. Nash TE, Pretell EJ, Lescano AG, et al.: Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: A prospective cohort and nested case-control study. Lancet Neurol 2008, 7:1099-1105.
43. Kowacs PA, Rogacheski E, Muzzio J, Werneck LC: The role of the irritative zone and of the number and distribution of calcifications in the severity of epilepsy associated with intracranial calcifications. Arq Neuropsiquiatr 2006, 64:905-911.
44. Pack AM, Morrell MJ, Marcus R, et al.: Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005, 57:252-257.
45. Perucca E: Treatment of epilepsy in DC. BMJ 2007, 334:1175-1176.
46. Kwan P, Brodie MJ: Phenobarbital for the treatment of epilepsy in the 21st century: A critical review. Epilepsia 2004, 45:1141-9114.
47. Banu SH, Jahan M, Koli UK, et al.: Side effects of phenobarbital and carbamazepine in childhood epilepsy: Randomized controlled trial. BMJ 2007,334: 1207.
48. Wang WZ, Wu JZ, Ma GY, et al.: Efficacy assessment of phenobarbital in epilepsy: A large, community-based intervention trial in rural China. Lancet Neurol 2006, 5:46-52.
49. Meinardi H, Scott RA, Reis R, Sander JW: The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001, 42:136-149.
50. Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in DC: A systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008, 49:1491-1503.
51. Sander JW: Global campaign against epilepsy. Overview of the demonstration projects. Epilepsia 2002, 43(Suppl 6):34-36.
52. Asadi-Pooya AA, Sperling MR: Strategies for surgical treatment of epilepsies in DC. Epilepsia 2008, 49:381-385.
53. Boling W, Palade A, Wabulya A, et al.: Surgery for pharmacoresistant epilepsy in the developing world: A pilot study. Epilepsia 2009 Jan 19 (Epub ahead of print).
54. Murthy JM: Some problems and pitfalls in developing countries. Epilepsia 2003, 44(Suppl 1):38-42.
55. Carpio A, Lisanti N, Calle H, et al.: Validation of a questionnaire for epilepsy diagnosis in primary care services. Rev Panam Salud Publica 2006, 19:157-162.
56. Balogou AA, Grunitzky EK, Belo M, et al.: Management of epilepsy patients in Batamariba district, Togo. Acta Neurol Scand 2007, 116:211-216.
57. Begley CE, Baker GA, Beghi E, et al.: Cross-country measures for monitoring epilepsy care. Epilepsia 2007, 48:990-1001.
58. Ding D, Hong Z, Wang WZ, et al.: Assessing the disease burden due to epilepsy by disability adjusted life year in rural China. Epilepsia 2006, 47:2032-2037.